查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386128

狂犬病疫苗市場報告：2030 年趨勢、預測與競爭分析

Rabies Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

狂犬病疫苗趨勢與預測

預計到 2030 年，全球狂犬病疫苗市場將達到 12 億美元，2024 年至 2030 年複合年成長率為 4.4%。該市場的主要驅動力是提高人們對狂犬病風險的認知，並配合措施控制狐狸和浣熊等野生動物族群的狂犬病。由於醫院、居家醫療和專科診所市場的機遇，全球狂犬病疫苗市場前景看好。

狂犬病疫苗市場洞察

Lucintel 預測，Vero 細胞由於其許多優點，包括可行性、安全性、高免疫抗原性以及可用於暴露前和暴露後預防的能力，預計在預測期內成長最快。

由於醫院狂犬病疫苗處方箋呈增加趨勢，預計該市場在預測期內將出現最高成長。

由於其強大的醫療基礎設施和不斷成長的製藥公司數量，預計北美仍將是最大的地區。

市場規模/估計：以金額估計狂犬病疫苗的市場規模（10 億美元）。

趨勢和預測分析：各個區隔市場和地區的市場趨勢（2018-2023）和預測（2024-2030）。

區隔分析：依產品類型、疫苗接種類型、應用、最終用途和地區等各個區隔市場估計狂犬病疫苗市場金額（以美元計）。

區域分析：北美、歐洲、亞太地區和世界其他地區的狂犬病疫苗市場區隔。

成長機會：依產品類型、疫苗類型、應用、最終用途和地區對狂犬病疫苗市場進行成長機會分析。

策略分析：狂犬病疫苗市場併購、新產品開發、競爭形勢等。

基於波特五力模型的產業競爭實力分析。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個區隔市場將以更快的速度成長？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球狂犬病疫苗市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球狂犬病疫苗市場趨勢（2018-2023）與預測（2024-2030）
  • 依產品類型分類的全球狂犬病疫苗市場
    • 倉鼠寶寶腎
    • 精製雞胚細胞狂犬病疫苗
    • Vero細胞狂犬病疫苗
    • 其他
  • 依疫苗類型分類的全球狂犬病疫苗市場
    • 暴露前疫苗接種 (PEV)
    • 暴露後預防 (PEP)
  • 全球狂犬病疫苗市場依應用
    • 動物
    • 人類
  • 全球狂犬病疫苗市場（依最終用途）
    • 醫院
    • 居家護理
    • 專科診所
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球狂犬病疫苗市場區域分佈
  • 北美狂犬病疫苗市場
  • 歐洲狂犬病疫苗市場
  • 亞太地區狂犬病疫苗市場
  • 其他地區狂犬病疫苗市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 依產品類型分類的全球狂犬病疫苗市場成長機會
    • 依疫苗類型分類的全球狂犬病疫苗市場成長機會
    • 全球狂犬病疫苗市場成長機會（依應用）
    • 全球狂犬病疫苗市場成長機會（依最終用途）
    • 全球狂犬病疫苗市場成長機會（依地區）
  • 全球狂犬病疫苗市場新趨勢
  • 戰略分析
    • 新產品開發
    • 全球狂犬病疫苗市場產能擴張
    • 全球狂犬病疫苗市場的合併、收購與合資企業
    • 認證和許可

第7章主要企業概況

  • Serum Institute of India
  • Novartis
  • Cadila Pharmaceuticals
  • Merck
  • Sanofi
  • ADS Diagnostic
  • GSK
簡介目錄

Rabies Vaccine Trends and Forecast

The future of the global rabies vaccine market looks promising with opportunities in the hospital, homecare, and specialty clinic markets. The global rabies vaccine market is expected to reach an estimated $1.2 billion by 2030 with a CAGR of 4.4% from 2024 to 2030. The major drivers for this market are rising awareness about the risks of rabies and growing efforts to control rabies in wildlife populations, such as foxes and raccoons.

A more than 150-page report is developed to help in your business decisions.

Rabies Vaccine by Segment

The study includes a forecast for the global rabies vaccine by product type, vaccination type, application, end use, and region.

Rabies Vaccine Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Baby Hamster Kidney
  • Purified Chick Embryo Cell Rabies Vaccine
  • Vero Cell Rabies Vaccine
  • Others

Rabies Vaccine Market by Vaccination Type [Shipment Analysis by Value from 2018 to 2030]:

  • Pre-Exposure Vaccination (PEV)
  • Post-Exposure Prophylaxis (PEP)

Rabies Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Animal
  • Human

Rabies Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Rabies Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Rabies Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies rabies vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the rabies vaccine companies profiled in this report include-

  • Serum Institute of India
  • Novartis
  • Cadila Pharmaceuticals
  • Merck
  • Sanofi
  • ADS Diagnostic
  • GSK

Rabies Vaccine Market Insights

Lucintel forecasts that vero cell is expected to witness highest growth over the forecast period due to its numerous benefits, such as its feasibility, safety, high immunogenicity, and can be used for pre- and post-exposure prophylaxis.

Within this market, hospital is expected to witness highest growth over the forecast period due to increasing rabies vaccination prescriptions tend to be issued within this facility.

North America will remain the largest region due to existence of robust healthcare infrastructure and expanding number of pharmaceutical companies in the region.

Features of the Global Rabies Vaccine Market

Market Size Estimates: Rabies vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Rabies vaccine market size by various segments, such as by product type, vaccination type, application, end use, and region in terms of ($B).

Regional Analysis: Rabies vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, vaccination types, applications, end uses, and regions for the rabies vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the rabies vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the rabies vaccine market size?

Answer: The global rabies vaccine market is expected to reach an estimated $1.2 billion by 2030.

Q.2 What is the growth forecast for rabies vaccine market?

Answer: The global rabies vaccine market is expected to grow with a CAGR of 4.4% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the rabies vaccine market?

Answer: The major drivers for this market are rising awareness about the risks of rabies and growing efforts to control rabies in wildlife populations, such as foxes and raccoons.

Q4. What are the major segments for rabies vaccine market?

Answer: The future of the rabies vaccine market looks promising with opportunities in the hospital, homecare, and specialty clinic markets.

Q5. Who are the key rabies vaccine market companies?

Answer: Some of the key rabies vaccine companies are as follows:

  • Serum Institute of India
  • Novartis
  • Cadila Pharmaceuticals
  • Merck
  • Sanofi
  • ADS Diagnostic
  • GSK

Q6. Which rabies vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that vero cell is expected to witness highest growth over the forecast period due to its numerous benefits, such as its feasibility, safety, high immunogenicity, and can be used for pre- and post-exposure prophylaxis.

Q7. In rabies vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to existence of robust healthcare infrastructure and expanding number of pharmaceutical companies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the rabies vaccine market by product type (baby hamster kidney, purified chick embryo cell rabies vaccine, vero cell rabies vaccine, and others), vaccination type (pre-exposure vaccination (PEV) and post-exposure prophylaxis (PEP)), application (animal and human), end use (hospitals, homecare, specialty clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Rabies Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Rabies Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Rabies Vaccine Market by Product Type
    • 3.3.1: Baby Hamster Kidney
    • 3.3.2: Purified Chick Embryo Cell Rabies Vaccine
    • 3.3.3: Vero Cell Rabies Vaccine
    • 3.3.4: Others
  • 3.4: Global Rabies Vaccine Market by Vaccination Type
    • 3.4.1: Pre-Exposure Vaccination (PEV)
    • 3.4.2: Post-Exposure Prophylaxis (PEP)
  • 3.5: Global Rabies Vaccine Market by Application
    • 3.5.1: Animal
    • 3.5.2: Human
  • 3.6: Global Rabies Vaccine Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Homecare
    • 3.6.3: Specialty Clinics
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Rabies Vaccine Market by Region
  • 4.2: North American Rabies Vaccine Market
    • 4.2.2: North American Rabies Vaccine Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others
  • 4.3: European Rabies Vaccine Market
    • 4.3.1: European Rabies Vaccine Market by Product Type: Baby Hamster Kidney, Purified Chick Embryo Cell Rabies Vaccine, Vero Cell Rabies Vaccine, and Others
    • 4.3.2: European Rabies Vaccine Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others
  • 4.4: APAC Rabies Vaccine Market
    • 4.4.1: APAC Rabies Vaccine Market by Product Type: Baby Hamster Kidney, Purified Chick Embryo Cell Rabies Vaccine, Vero Cell Rabies Vaccine, and Others
    • 4.4.2: APAC Rabies Vaccine Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others
  • 4.5: ROW Rabies Vaccine Market
    • 4.5.1: ROW Rabies Vaccine Market by Product Type: Baby Hamster Kidney, Purified Chick Embryo Cell Rabies Vaccine, Vero Cell Rabies Vaccine, and Others
    • 4.5.2: ROW Rabies Vaccine Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Rabies Vaccine Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Rabies Vaccine Market by Vaccination Type
    • 6.1.3: Growth Opportunities for the Global Rabies Vaccine Market by Application
    • 6.1.4: Growth Opportunities for the Global Rabies Vaccine Market by End Use
    • 6.1.5: Growth Opportunities for the Global Rabies Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Rabies Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Rabies Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Rabies Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Serum Institute of India
  • 7.2: Novartis
  • 7.3: Cadila Pharmaceuticals
  • 7.4: Merck
  • 7.5: Sanofi
  • 7.6: ADS Diagnostic
  • 7.7: GSK